Skip to main content Skip to office menu Skip to footer
Capital IconMinnesota Legislature
  1. LRL Home
  2. Mandate Search
  3. Mandate Detail

Mandate Details

Description: Report on the implementation of prescription drug price transparency under this section, including promoting transparency in pharmaceutical pricing for the state and other payers; enhancing the understanding on pharmaceutical spending trends; and assisting the state and other payers in the management of pharmaceutical costs.The report must include a summary of the information that drug manufacturers submit under Subs. 3, 4, and 5.
Law: 2020 Minn. Laws Chap. 78 Sec. 1 Subd. 9
Statute: 62J.84 Subd. 9
Agency(ies)/Supplier(s): Minn. Dept. of Health
Due Date: 01/15/2026
Frequency: Annual
Topics: Health Care - Costs & Financing
Health Care - Pharmaceuticals
Mandate Groups: Commerce
Health
Committee/Agency Jurisdiction: Commerce
Health and Human Services Policy and Finance
Note: The Minn. Dept. of Health plans to publish this report in the first week of the 2024 legislative session.

Item(s) Received

TitlePublisher(s)Publication DateCoverageDate ReceivedReport Link
Minnesota Prescription Drug Price Transparency: Report to the Minnesota Legislature Minn. Dept. of Health November 2025July 1, 2023 - June 30, 202411/06/2025 25-1732.pdf
Minnesota Prescription Drug Price Transparency: Report to the Minnesota Legislature Minn. Dept. of Health May 2024January 1, 2022 - June 30, 202307/01/2024 24-1001.pdf
Minnesota Prescription Drug Price Transparency: Report to the Minnesota Legislature Minn. Dept. of Health September 8, 2023Through November 202209/11/2023 23-1462.pdf
Minnesota Prescription Drug Price Transparency: Report to the Minnesota Legislature February 2023First half of 202203/15/2023 23-0635.pdf